Isocitrate Dehydrogenase Inhibitors Market to Surge to $3.2B by 2032
The global isocitrate dehydrogenase inhibitors market size is a critical indicator of the accelerating shift towards precision oncology and targeted cancer therapies. According to WiseGuy Reports, the market was valued at 1.36 billion USD in 2024 and is projected to reach 3.2 billion USD by 2032. This trajectory, representing a compound annual growth rate (CAGR) of 11.25% over the...
0 Comentários 0 Compartilhamentos 33 Visualizações 0 Anterior